News

  • Group launches to become permanent home for Britain’s founder-led medtech firms

    A new investment group has launched with the aim of buying and permanently holding successful British medtech companies, offering their founders an alternative to selling to private equity firms or larger rivals. Qualeris, based in Birmingham, was founded by Peter Dines, a medtech chief executive, investor and board director with three decades of experience in [...]

  • Antimicrobial resistance innovation secures commercial partner

    AseptiFlow has secured a commercial partner as the NHS-developed device moves towards wider deployment in healthcare settings worldwide. The device, invented and developed by Dr James Soothill, consultant microbiologist at Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH), has been licensed to Mueller Europe Ltd for commercial manufacture and adoption across hospitals, care [...]

  • Pig kidney transplant keeps man off dialysis for nine months in world first

    A pig kidney transplant kept a man off dialysis for nine months, the longest reported dialysis-free survival after the procedure in a living human. The genetically modified organ functioned for 271 days before the patient moved to short-term dialysis and later received a human donor kidney. The case also marked the first transition from a [...]

  • New AI platform aims to transform surgical training globally

    Surgeon.AI has launched an AI-powered platform combining surgical education, career development and personalised learning for surgeons worldwide. Professor Shafi Ahmed, a surgeon and healthcare technology innovator, launched the platform to support surgeons from medical school and training through to consultant or attending level. Central to the platform is ELLA, the Education, Learning and Language Agent, [...]

  • Oura set to list on US stock market

    Oura's revenue rose to US$1.2bn in the nine months to 30 June as the wearable maker moves towards a US IPO. A filing with the Securities and Exchange Commission on Thursday showed revenue increased from US$697m in the same nine-month period a year earlier. Oura has previously said it generated US$500m in revenue in 2024 [...]

  • New webinar on the role AI can play in supporting Welsh primary care

    GP practices across Wales are being invited to a new webinar exploring the practical role AI could play in supporting primary care teams as they manage rising workloads and continued digital transformation. Improving Clinical Coding in Wales with BetterLetter will take place on Wednesday 23 September, from 12pm to 12.45pm BST. The free session will [...]

  • AI scribes used by doctors may miss vital body language cues, study warns

    AI scribes used by doctors may miss body language and other non-verbal cues that can contain clinically important information, a review has warned. The technology converts spoken consultations into text and generates summaries, but researchers said it cannot capture gestures, facial expressions, movement or emotional cues. Academics at the University of Edinburgh raised [...]

  • Patient preference science is changing how we define a better treatment

    By Sanius Health As we enjoy the last days of Summer and head into September, one of the clearest shifts we are seeing across life sciences is a surge in demand for patient preference science. Some of that momentum reflects the work of Kielo Health, Sanius Health’s preference science division, led by Dr Tommi Tervonen, [...]

  • New Zealand approves use of MDMA for severe PTSD

    New Zealand has approved MDMA for treating severe PTSD, becoming the second country after Australia to permit its use for the condition. The approval was granted by New Zealand's pharmaceutical regulator, Medsafe, and follows Australia's 2023 decision to approve psychedelics for PTSD and treatment-resistant depression. Two psychiatrists have been authorised to prescribe pharmaceutical-grade [...]

  • Elucid secures US$55m for AI cardio imaging tech

    Elucid has raised US$55m in Series D financing to expand its AI cardiovascular imaging platforms and advance BioIntegrated FFR-CT through FDA clearance. The Boston-based medical technology company said the oversubscribed round brings its total funding to approximately US$185m. The funding will support commercial expansion of Elucid's clinical platforms, further research and development, clinical studies and [...]